This study is for patients with a type of lung cancer called non-small cell lung cancer (NSCLC), which has been or will be removed by surgery. The study looks at the genes in the cancer cells to help doctors choose the best treatment. The main goal is to test for genetic changes in the cancer to help find new treatments.

Key points:

• Participation involves genetic testing and possibly receiving different types of treatments.
• The study may last up to 5 years with regular follow-ups every 6 months.
• Patients may receive compensation if participating in treatment trials.

Patients need to provide blood and tissue samples for testing. The study checks for changes in specific genes such as EGFR, ALK, and PD-L1, which may influence treatment options. If you have surgery before joining the study, your previous tissue samples will be used for testing. The study also observes how lung cancer changes over time and how these changes affect treatment. Eligibility includes being 18 or older, having a specific stage of cancer, and not having had certain treatments before. Women who are pregnant or breastfeeding cannot join. This study could help improve future lung cancer treatments by finding targeted therapies.